INAB – in8bio, inc. (US:NASDAQ)
Stock Stats
News
IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress [Yahoo! Finance]
IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
IN8bio, Inc. (NASDAQ: INAB) had its price target lowered by analysts at HC Wainwright from $14.00 to $12.50. They now have a "buy" rating on the stock.
IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024 [Yahoo! Finance]
IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024
Form 10-Q IN8BIO, INC. For: Mar 31
Form 8-K IN8BIO, INC. For: May 09
Form 424B5 IN8BIO, INC.
Form ARS IN8BIO, INC. For: Dec 31
Form DEFA14A IN8BIO, INC.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.